Sign in
Taking people in United StatesPhase 1

Metabolic Impact of Pancreatic Duct Decompression

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 1
People taking part
30 people, planned
Started
30 Oct 2026
Expected to end
Mar 2030
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Endoscopic pancreatic duct decompression
Record updated
3 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged ≥ 18
  • Chronic pancreatitis as defined by Cambridge grade 3 or 4 (3: > 3 abnormal side branches; 4: abnormal main duct and branches) pancreatic ductal changes and/or parenchymal and/or intraductal calcifications (chronic calcific pancreatitis) by CT Scan or MRI/MRCP24
  • Minimally symptomatic:; Asymptomatic patients who were incidentally diagnosed with chronic pancreatitis based on imaging; Mild to moderate pain (visual analog scale ≤ 5) who do not require daily opioid pain medications; ≤ 1 episode of uncomplicated acute pancreatitis in 12 months prior to enrollment

Who cannot take part

  • Prior pancreatic surgery
  • Concurrent extra-pancreatic malignancy other than non-melanoma skin cancer
  • Prior endoscopic therapy for pancreatic duct obstruction
  • Acute pancreatitis < 90 days prior to enrollment
  • Pancreatic head mass or suspicion for pancreatic malignancy
  • History of diabetes (defined as either a HbA1c ≥ 6.5 % or a fasting glucose ≥ 126 mg/dL)
  • Pancreatic duct obstruction limited to the tail of pancreas
  • Surgically altered forgot anatomy prohibitive of ERCP with standard techniques (e.g Billroth II, Roux-en-y gastric bypass, pancreaticoduodenectomy)
  • Active alcohol use within 2 months of enrollment
  • Gastrointestinal stricture/obstruction precluding passage of the duodenoscope to the papilla
  • Standard contraindications to ERCP
  • Unable to receive general anesthesia

Where in United States

  • Mayo ClinicRochester, United StatesContact: LUis Ospina VelasquezTaking people

About the trial

What the trial wants to find out

This study is a pilot study evaluating the impact of clearing out the pancreatic duct in patients with chronic pancreatitis who have a blockage in their pancreatic duct. While we typically perform procedures with an endoscope (a long flexible tube with a camera that goes through the mouth to reach the small intestine) to relieve a pancreatic duct blockage in patients with chronic pancreatitis who have pain and have a blockage, we do not know how relieving this blockage improves pancreatic function. Therefore, we are performing a preliminary study where participants will be randomized to either receiving an endoscopy or not undergoing an endoscopy. This will provide some background data to help inform us whether we should perform a larger study in the future to answer this question.

The 2 groups in the trial

  • Endoscopic pancreatic duct decompression (Intervention Arm)Treatment being tested

    Participants in the intervention arm will receive endoscopic pancreatic duct decompression.

    Treatment: Endoscopic pancreatic duct decompression

  • No endoscopic intervention (Control Arm)No study treatment, for comparison

    The control arm will receive medical management alone, defined as standard of care treatment per the discretion of the treating pancreatologist.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Metabolic Impact of Endoscopic Pancreatic Duct Decompression: A Pilot Study
Record updated
3 November 2026